Toggle Dropdown
Groups
Announcements
Projects
News & Events
Welcome guest
Log in
Friends
Loading
Loading...
Announcements
Projects
Orgs
Project
Articles 42
Votes 0
FierceBiotech
Home
Articles
Authors
6
Ben Adams
Helen Floersh
FierceBiotech
James Waldron
Max Bayer
Nick Paul Taylor
1
2
Next
»
Intellia pauses phase 3 CRISPR trials after patient is hospitalized - Fierce Biotech
~2mo
Celcuity's breast cancer combo hits goals, teeing up FDA filing - Fierce Biotech
5mo
Recursion lays off 20% of staff in wake of pipeline cutbacks - Fierce Biotech
6mo
JPM24: Lilly CEO David Ricks to biotechs: 'We're open for business' - FierceBiotech
almost2y
JPM24, Day 2: GSK, Eli Lilly, Blueprint, SR One and more - FierceBiotech
almost2y
Drug more effective on pain than gabapentin, minus side effects - FierceBiotech
~2y
Hepatitis B drug developers chart slow progress forward, just like hep C before it - FierceBiotech
~2y
Verve shows base editing works in humans in first clinical data—and is punished by investors - FierceBiotech
~2y
AstraZeneca's long-term GLP-1 play is weight management, not obesity, CEO says - FierceBiotech
~2y
CRISPR-Vertex gene editing 1st gets narrow review by FDA panel - FierceBiotech
~2y
Merck pays $4B for Daiichi ADCs in bet on post-Keytruda future - FierceBiotech
~2y
Beam lays off 20% of staff and culls CAR-T work to save cash - FierceBiotech
~2y
Akero's NASH miss drags a few peers down, spurring deja vu in long-challenging indication - FierceBiotech
~2y
FDA hopes to spur stimulant use disorder drug development - FierceBiotech
~2y
FDA's single-trial guidance calls for the good, bad and ugly data to support effectiveness - FierceBiotech
~2y
GE HealthCare scores $44M Gates grant for AI-powered ultrasound - FierceBiotech
~2y
RayzeBio scores $311M oversized IPO, Neumora hits $250M target - FierceBiotech
>2y
Carl June, Vertex execs and Parkinson's scientists win Breakthrough prizes - FierceBiotech
>2y
BMS trims anti-TIGIT and a handful of other meds - FierceBiotech
>2y
BMS trims anti-TIGIT and a handful of other meds - FierceBiotech
>2y
Italian billionaires behind Ferrari, Juventus drop $2.8B to become Philips' largest shareholder - FierceBiotech
>2y
One injection to cure sickle cell? Researchers give it a shot with new mRNA gene therapy - FierceBiotech
>2y
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data - FierceBiotech
>2y
CRISPR helps solve 100-year mystery of why cancer cells have extra chromosomes - FierceBiotech
>2y
First-gen mRNA flu vaccines 'will not win,' Sanofi execs admit as they retool strategy - FierceBiotech
>2y
1
2
Next
»
Modal title
...
Profile
Loading profile
Loading...